The Behavior Shapers
The $200 Billion Friction Machine
Utilization management, prior authorization, and the administrative war between payers and providers
Three Numbers That Should Stop Every Executive
Estimated annual cost of administrative friction between payers and providers in the United States — the money consumed by processes designed to manage what care gets delivered, where it gets delivered, and whether it gets paid for. It is not the cost of care. It is the cost of arguing about care.
How much hospitals and health systems spent in a single year just on appealing denied claims. Not on delivering care. Not on improving quality. On fighting to get paid for care they already delivered, much of which was pre-authorized before it was provided, and more than half of which was ultimately paid after the appeal was won.
Percentage of physicians who report that prior authorization delays access to necessary patient care — care that, when delayed, frequently results in emergency department visits, hospitalizations, and treatment abandonment that increases total cost rather than reducing it.
Zone 3 — the Behavior Shapers — is where payer/provider contracts govern the daily operational reality of how care is delivered and reimbursed. These provisions are supposed to ensure that the right care is delivered in the right setting at the right cost. Instead, they have become the most expensive, most contentious, and most strategically underexamined zone in the entire contract.
The Anatomy of Utilization Management
Utilization management (UM) is the umbrella term for the set of processes payers use to evaluate whether a proposed or delivered service is medically necessary, appropriate, and cost-effective. UM operates at three temporal points:
Prospective Review: Prior Authorization
Requires provider to obtain approval before delivering service. Payer's clinical team reviews request and either approves, denies, or requests additional information.
Scale:
Physicians complete average of 43 prior authorizations per week, consuming ~12 hours of physician and staff time weekly. Billions of transactions annually across U.S. healthcare system.
The Paradox:
87% of physicians report PA leads to HIGHER overall healthcare resource utilization — delays lead to disease progression, emergency care, hospitalization. 29% report PA has led to serious adverse event for a patient in their care.
Concurrent Review
Evaluates medical necessity during care delivery — typically for inpatient stays. UM team reviews admission and ongoing length of stay, often daily or every-other-day.
Negotiation Implications:
Determines how much clinical documentation provider must produce during admission, review frequency, peer-to-peer process for disagreements, and payment consequences if payer determines part of stay was not medically necessary.
The Paradox:
Concurrent review denial that retroactively de-certifies last 3 days of 7-day admission may trigger reclassification of entire stay, changing DRG assignment — not just reducing payment for those 3 days.
Retrospective Review
Occurs after care delivered and claim submitted. Payer reviews for medical necessity, coding accuracy, and compliance with contract terms. Where the denial economy operates at full scale.
Scale:
Nearly 15% of all claims initially denied. In Medicare Advantage, initial denial rate reached 17%. DRG downgrades increased 57% between 2022-2023. Final denial rate after all appeals: 2.8%.
The Paradox:
More than 54% of denied claims that are appealed are ultimately overturned and paid. In some states, overturn rate reaches 60-80%. This means more than half of denials are INCORRECT — care was medically necessary, claim properly coded, payment should have been made first time.
Prior Authorization: The Provision-by-Provision Negotiation
Prior authorization is not a single contract provision. It is a system of interlocking provisions, each of which can be negotiated — and each of which interacts with economics in Zones 1 and 2.
PA Scope: What Requires Authorization
The Most Fundamental Negotiation
Which services require prior authorization? Broader list = greater administrative burden and payer control. Narrower list = lower friction but lower payer utilization management capability.
The Architect's Strategy:
Analyze provider's historical approval rate for each PA-required service. For services where approval rate exceeds 90-95%, PA generates administrative cost without managing utilization — most requests approved anyway.
Negotiation Approach:
Propose tiered PA structure: Tier 1 (No PA) for >95% approval rate services. Tier 2 (Streamlined PA) for 80-95% approval rate. Tier 3 (Full PA) for <80% approval rate where genuine clinical variation benefits from review.
PA Turnaround Times
How Quickly Must Payer Respond
CMS Final Rule requires 72 hours for urgent requests, 7 days for standard. Commercial contracts can negotiate tighter standards, particularly for time-sensitive services.
The Architect's Strategy:
Every day PA request sits in queue = patient waits, physician schedule disrupts, provider revenue delays. For surgical procedures, PA delays can push cases out of scheduling window, costing thousands per delayed case.
Negotiation Approach:
Negotiate specific turnaround times by service category with financial consequences for non-compliance. Example: "Urgent PA within 24 hours; standard PA within 48 hours for imaging, 72 hours for surgical. Each PA exceeding standard = $250 credit to provider administrative account."
PA Validity Period and Continuity
How Long Does Approval Last
How long does PA approval remain valid? What happens when treatment requires ongoing authorization (chemo, behavioral health, chronic condition management)?
The Architect's Strategy:
PA that expires after 30 days for treatment requiring 12 weeks forces re-authorization 3 additional times — generating administrative cost and 3 more denial opportunities.
Negotiation Approach:
Negotiate PA validity periods matching clinical treatment timelines. For ongoing treatments, negotiate "PA continuity": once authorized, authorization remains valid for duration of treatment plan without re-authorization. For patients transitioning plans, negotiate "PA portability": new plan must honor prior plan's PA for minimum 90 days.
Peer-to-Peer Review Process
When PA Request Is Denied
Provider's attending physician has right to discuss case with payer's medical director in peer-to-peer review. Often most effective intervention for overturning inappropriate denials.
The Architect's Strategy:
Many payers make peer-to-peer difficult to access — requiring wait on hold, inconvenient scheduling hours, narrow window after denial. These friction points discourage utilization, effectively converting clinical review into rubber stamp for denials.
Negotiation Approach:
Negotiate guaranteed peer-to-peer access within 24 hours of denial, with option for provider physician to initiate at mutually convenient time. Negotiate that peer-to-peer reviewers must be board-certified in same specialty as treating physician.
Gold Card Provisions
Exemptions for High-Performing Providers
Gold card provisions contractually exempt providers with high PA approval rates from PA requirements for specific services — mirroring legislative gold card reforms in Texas, Wyoming, Colorado, and other states.
The Architect's Strategy:
Even in states without gold card legislation, negotiate contractual provisions that create self-adjusting PA system responding to actual data rather than blanket requirements.
Negotiation Approach:
Contract language: "For any service category where provider's PA approval rate exceeds 95% over trailing 12-month period, PA requirements automatically waived for subsequent 12-month period, subject to reinstatement if approval rate falls below 90%."
Your Prior Authorization Negotiation Strategy
For your next contract negotiation, identify which PA provisions need immediate attention. Which services have >95% approval rates that should be Tier 1? What turnaround times will you demand? How will you structure gold card provisions?
The Denial Economy: Negotiating the Back End
The Numbers That Define the Denial Economy:
15%
Initial denial rate for private payer claims
54%
Of denied claims appealed are ultimately overturned
$43.84
Provider administrative cost per denied claim
The overturn rate tells the deeper story: More than half of denials are incorrect — the care was medically necessary, the claim was properly coded, and the payment should have been made the first time.
If prior authorization is the front end of the Behavior Shaper system, claims denial management is the back end — and it is where billions of dollars are silently transferred from providers to payers through administrative process rather than negotiated rate concessions.
Clean Claim Standards and Payment Timelines
A "clean claim" is claim submitted with all required data elements, in correct format, within filing deadline. Contract defines what constitutes clean claim and how quickly payer must pay it.
The Trap:
Payer that defines clean claims narrowly — requiring additional data elements, specific modifier usage, or documentation attachments beyond industry standards — can reject claims as "not clean" and restart payment clock.
The Architect's Solution:
Define clean claim criteria explicitly in contract using HIPAA 837 standard as baseline, with any additional requirements listed exhaustively. Negotiate payment timeline of 15-20 days for electronic clean claims with interest penalties for late payment. Negotiate auto-adjudication commitment for claims meeting clean claim criteria.
Denial Reason Specificity
When claim denied, specificity of denial reason determines how quickly and effectively provider can respond. Many denials issued with vague reason codes that don't give provider enough information to correct issue or build appeal.
The Trap:
CMS Final Rule now requires impacted payers to provide specific reason for denied PA decisions beginning 2026. But this doesn't cover all commercial claims — and contract can go further.
The Architect's Solution:
Negotiate contractual requirement for specific, clinically substantive denial reasons — not just CARC/RARC codes, but written explanation referencing specific clinical criteria payer applied and specific documentation element found deficient. Forces payer to substantiate every denial with clinical reasoning, discouraging pro forma denials.
Denial Rate Monitoring and Accountability
Perhaps most powerful — and least commonly negotiated — Behavior Shaper provision: contractual mechanism that monitors denial patterns and creates accountability for excessive or inappropriate denials.
The Trap:
Without contractual accountability, excessive denials have no consequences for payer's UM operation. Cost of inappropriate denials falls entirely on provider.
The Architect's Solution:
Negotiate denial rate monitoring: "Parties will jointly review denial rates quarterly. If initial denial rate for clean claims exceeds [X]% in any quarter, and overturn rate on appeal exceeds [Y]%, payer will conduct root cause analysis and implement corrective action within 60 days. If pattern persists for two consecutive quarters, provider may invoke dispute resolution process." Creates transparency and accountability — changes incentive calculus for payer's UM operation.
Your Denial Management Negotiation Strategy
How will you negotiate clean claim standards, denial reason specificity, and denial rate accountability in your next contract? What financial consequences will you demand for excessive denial rates or late payments?
The Zone 3 / Zone 2 Interaction
The most critical interaction in the contract ecosystem is between Zone 3 Behavior Shapers and Zone 2 Risk and Reward provisions. This interaction determines whether VBC arrangements work as designed — or whether they are undermined by the very administrative processes that were supposed to support them.
The PA/VBC Conflict
The Problem:
Provider in shared savings arrangement is accountable for total cost of care. To manage cost, provider needs to direct patients to appropriate settings, intervene early, coordinate care. But payer's PA requirements create friction at every intervention point — delaying referrals, blocking preventive services, consuming clinical staff time. In extreme version: payer's UM operation is actively BLOCKING the very care management interventions that payer's VBC team is paying provider to implement.
The Architect's Response:
Negotiate UM waivers for VBC-attributed populations. If provider is financially accountable for total cost of care, provider — not payer's UM team — should be making utilization decisions. Contract language: "For patients attributed to provider under VBC arrangement, prior authorization requirements are waived for [defined list of services]. Provider assumes clinical and financial responsibility for utilization decisions within VBC framework." Aligns Zone 3 behavior management with Zone 2 financial accountability.
The Denial/VBC Conflict
The Problem:
Claims denied during performance period still flow through TCOC calculation in many VBC arrangements — meaning provider is accountable for total cost that includes claims provider wasn't paid for. Appeals that reverse denials months after performance period may not be captured in reconciliation.
The Architect's Response:
Negotiate that VBC TCOC calculations based on allowed amounts (what payer would have paid), not paid amounts (what payer actually paid after denials). Removes perverse incentive where payer can reduce its TCOC exposure by denying claims. Alternatively, negotiate that denied claims excluded from TCOC calculations until final resolution — ensuring provider isn't penalized for administrative disputes while being accountable for clinical management.
The contract that simultaneously holds the provider accountable for population health outcomes and blocks the provider from managing population health through excessive PA requirements
is a contract at war with itself.
Site-of-Service Provisions: The Quiet Revolution
The Current Landscape:
Medicare and commercial payers pay dramatically different amounts for the same service depending on where it is delivered. A clinic visit in a hospital outpatient department (HOPD) typically generates two bills — professional fee and facility fee — that together may be 2-3x higher than the single professional fee for same visit in freestanding physician office.
This differential has driven two decades of hospital acquisition of physician practices. From 2012-2022, spending on hospital outpatient services increased 73%, and as of 2022, hospitals owned 53.6% of physician practices.
The Site-Neutrality Movement:
Site-neutral payment reform — policy that Medicare should pay same rate for same service regardless of care setting — has gained decisive momentum. Bipartisan Budget Act of 2015 began the process. Bipartisan Senate framework introduced in 2025 would eliminate grandfather exemption and expand site-neutral payments broadly.
Strategic Implications:
For Providers: Hospitals that built growth strategy around HOPD facility fees face significant revenue risk. If broadly implemented, site neutrality would materially impact outpatient department profitability — particularly for academic medical centers and systems with large HOPD footprints.
For Payers: Site-of-service provisions in commercial contracts can precede regulatory reform — many payers already implementing contractual differentials that steer services to lower-cost settings through benefit design, tiered reimbursement, or explicit site-of-service restrictions.
Negotiating Site-of-Service Provisions:
For Providers:
Negotiate clinical appropriateness criteria for site-of-service determinations. Not all services are interchangeable across settings — patient with multiple comorbidities may require hospital-based imaging with emergency response capability. Contract should differentiate between "shoppable" services and services requiring hospital infrastructure for patient safety.
For Payers:
Design site-of-service provisions with geographic access standards, clinical exception pathways, and phase-in periods giving providers time to restructure care delivery. Most effective provisions are not mandates — they are incentive structures making lower-cost settings financially attractive for appropriate services while preserving access for complex cases.
Designing Zone 3 for the Future
The regulatory landscape for Zone 3 is shifting rapidly. CMS Interoperability and Prior Authorization Final Rule requires electronic PA, specific denial reasons, and public reporting of PA metrics beginning 2026. Gold card legislation continues to spread. Site-neutrality reform is gaining momentum.
The Architect negotiator designs Zone 3 provisions that anticipate these changes rather than react to them.
- • Build PA reform into contract before legislation mandates it
- • Design site-of-service provisions that create managed transition pathway rather than cliff
- • Align Zone 3 with Zone 2 so UM supports rather than undermines VBC
- • Invest in joint administrative simplification — $200B in annual friction is pure waste
Your Zone 3 Strategic Reflection
The Behavior Shapers are the most operationally intensive zone in the contract — the provisions clinical and administrative staff interact with hundreds of times daily. They are also provisions most likely to be accepted as "standard" without negotiation. They are not non-negotiable. Every provision in this chapter is a contractual term that can be proposed, countered, modified, and agreed upon.
Zone 3 is where the contract meets the patient. Design it accordingly.